The malaria and sickle cell disease treatment market is expected to grow from US$ 4.457 billion in 2022 to US$ 29.179 billion by 2030; it is estimated to grow at a CAGR of 26.5% from 2022 to 2030. The market for malaria and sickle cell disease treatment is growing due to the increasing prevalence of malaria and sickle cell disease and rising government initiatives to raise awareness about malaria and SCD. However, factors such as a counterfeit antimalarial drug and subsequent drug resistance are restraining the market growth.
Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial and SCD drug/vaccine pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria and sickle cell disease. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options.
The report segments the malaria and sickle cell disease treatment market as follows:
The malaria and sickle cell disease (SCD) treatment market is segmented on the basis of treatment, route of administration, distribution channel, and geography. Based on treatment, the market is divided into malaria and sickle cell disease. In terms of route of administration, the malaria and sickle cell disease (SCD) treatment market is divided into oral and parenteral. Based on distribution channel, the market is categorized into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. By geography, the malaria and sickle cell disease treatment market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, Kenya, Tanzania, Rwanda, Nigeria, Ghana, Uganda, Angola, Cameroon, Senegal, Zambia, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Route of Administration-Based Insights
By route of administration, the malaria treatment market is bifurcated into oral and parenteral. In 2022, the oral segment held a larger market share, and the parenteral segment is estimated to record a faster CAGR during 2020-2030. Oral drug delivery is the most ideal and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form, and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are the major factors fueling the adoption of oral drugs.
Distribution Channel-Based Insights
Based on distribution channel, the malaria and sickle cell disease (SCD) treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022. A tender is an offer to do specific duties or provide items for a fixed amount. In the first step of a tender procedure, contractors will be asked to submit sealed bids for construction or to offer particularly planned services or products within a specific time limit. The e-tendering procedure in India is designed to ensure that work for the government or a specific client is completed in a timely manner.
A few of the major primary and secondary sources referred to while preparing the report on the malaria and sickle cell disease treatment market are the World Health Organization (WHO), the US Census Bureau, and CDC, among others.
Table of Contents
1.2 Market Segmentation
2.2 Key Insights - Sickle Cell Disease
3.2 Secondary Research
3.3 Primary Research
4.2 PEST Analysis - Malaria Treatment
4.3 PEST Analysis - Sickle Cell Disease Treatment
5.1.1 Increasing Prevalence of Malaria and Sickle Cell Disease
5.1.2 Rising Initiatives to Raise Awareness about Malaria and SCD
5.2 Market Restraints
5.2.1 Lack of Sickle Cell Disease Treatment Options and Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
5.3 Market Opportunities
5.3.1 Growing Strategic Initiatives by Market Players
5.4 Future Trends
5.4.1 Extending Pipeline of New Drugs and Vaccines
5.5 Impact Analysis
6.2 Sickle Cell Disease Treatment Market Revenue (US$ million), 2022 - 2030
6.3 Geography Analysis Market Revenue (US$ million), 2022 - 2030
6.4 Epidemiology Data for Malaria
6.4.1 Malaria Transmission Characteristics, Immunity, and Clinical Features
6.4.2 Estimated Malaria Cases and Deaths
6.4.2.1 Fundings for Malaria-Related R&D, 2021
6.4.2.2 Fundings for Malaria Control, 2021
6.5 Funding Allocation Mechanism
6.5.1 Global Funds
6.5.1.1 USAID: Burundi-Malaria Operational Plan FY 2022
6.5.1.2 Procurement Scenario For Malaria Drugs
6.6 Reimbursement Scenario for Malaria
6.6.1 Overview
6.7 Sickle Cell Disease
6.7.1.1 Epidemiology Data of Sickle Cell Disease (SCD), 2020
6.8 Fundings for Sickle Cell Disease (SCD)
6.9 Reimbursement Scenario for Sickle Cell Disease
6.9.1 Overview
6.10 Number of Healthcare Facilities and Healthcare Expenditure:
7.2 Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
7.3 Overview
7.4 Sickle Cell Disease Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
7.5 Malaria
7.5.1 Overview
7.5.2 Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Malaria Treatment Market, by Treatment
7.6 Sickle Cell Disease (SCD)
7.6.1 Overview
7.6.2 Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 Sickle Cell Disease Treatment Market, by Treatment
8.2 Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.3 Overview
8.4 Sickle Cell Disease Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.5 Oral
8.5.1 Overview
8.5.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.5.3 Oral: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Parenteral
8.6.1 Overview
8.6.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.6.3 Parenteral: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Overview
9.4 Sickle Cell Disease Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.5 Direct Tender
9.5.1 Overview
9.5.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.5.3 Direct Tender: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Hospital Pharmacies
9.6.1 Overview
9.6.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
9.6.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
9.6.3 Hospital Pharmacies: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.6.3.1.1 Sickle Cell Disease Treatment Market, by Hospital Pharmacies
9.7 Retail Pharmacies
9.7.1 Overview
9.7.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.7.2.1.1 Malaria Treatment Market, by Retail Pharmacies
9.7.3 Retail Pharmacies: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.7.3.1.1 Sickle Cell Disease Treatment Market, by Retail Pharmacies
9.8 Online Pharmacies
9.8.1 Overview
9.8.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.8.3 Online Pharmacies: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others : Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.9.3 Others: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1 Overview
10.1.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.1 North America: Malaria Treatment Market, by Treatment
10.1.3.2 North America: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.3 North America: Malaria Treatment Market, by Route of Administration
10.1.3.4 North America: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.5 North America: Malaria Treatment Market, by Distribution Channel
10.1.3.5.1 North America: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.5.2 North America: Malaria Treatment Market, by Retail Pharmacies
10.1.3.6 North America: Sickle Cell Treatment Market, by Distribution Channel
10.1.3.6.1 North America: Sickle Cell Treatment Market, by Hospital Pharmacies
10.1.3.6.2 North America: Sickle Cell Treatment Market, by Retail Pharmacies
10.1.3.7 North America: Malaria Treatment Market, by Country
10.1.3.8 North America: Sickle Cell Disease Treatment Market, by Country
10.1.3.9 US
10.1.3.10 Overview
10.1.3.10.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.10.2 US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.10.3 US: Malaria Treatment Market, by Treatment
10.1.3.10.4 US: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.10.5 US: Malaria -Malaria Treatment Market, by Route of Administration
10.1.3.10.6 US: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.10.7 US: Malaria Treatment Market, by Distribution Channel
10.1.3.10.7.1 US: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.10.7.2 US: Malaria Treatment Market, by Retail Pharmacies
10.1.3.10.8 US: Sickle Cell Disease Treatment Market, by Distribution Channel
10.1.3.10.8.1 US: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.1.3.10.8.2 US: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.1.3.11 Canada
10.1.3.12 Overview
10.1.3.12.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.12.2 Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.12.3 Canada: Malaria Treatment Market, by Treatment
10.1.3.12.4 Canada: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.12.5 Canada: Malaria -Malaria Treatment Market, by Route of Administration
10.1.3.12.6 Canada: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.12.7 Canada: Malaria Treatment Market, by Distribution Channel
10.1.3.12.7.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.12.7.2 Canada: Malaria Treatment Market, by Retail Pharmacies
10.1.3.12.8 Canada: Sickle Cell Disease Treatment Market, by Distribution Channel
10.1.3.12.8.1 Canada: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.1.3.12.8.2 Canada: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.1.3.13 Mexico
10.1.3.14 Overview
10.1.3.14.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.14.2 Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.14.3 Mexico: Malaria Treatment Market, by Treatment
10.1.3.14.4 Mexico: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.14.5 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
10.1.3.14.6 Mexico: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.14.7 Mexico: Malaria Treatment Market, by Distribution Channel
10.1.3.14.7.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.14.7.2 Mexico: Malaria Treatment Market, by Retail Pharmacies
10.1.3.14.8 Mexico: Sickle Cell Disease Treatment Market, by Distribution Channel
10.1.3.14.8.1 Mexico: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.1.3.14.8.2 Mexico: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2 Europe Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.2.1 Overview
10.2.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.1 Europe: Malaria Treatment Market, by Treatment
10.2.3.2 Europe: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.3 Europe: Malaria Treatment Market, by Route of Administration
10.2.3.4 Europe: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.5 Europe: Malaria Treatment Market, by Distribution Channel
10.2.3.5.1 Europe: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.5.2 Europe: Malaria Treatment Market, by Retail Pharmacies
10.2.3.6 Europe: Sickle Cell Treatment Market, by Distribution Channel
10.2.3.6.1 Europe: Sickle Cell Treatment Market, by Hospital Pharmacies
10.2.3.6.2 Europe: Sickle Cell Treatment Market, by Retail Pharmacies
10.2.3.7 Europe: Malaria Treatment Market, by Countries
10.2.3.8 Europe: Sickle Cell Disease Treatment Market, by Countries
10.2.3.9 France
10.2.3.10 Overview
10.2.3.10.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.10.2 France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.10.3 France: Malaria Treatment Market, by Treatment
10.2.3.10.4 France: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.10.5 France: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.10.6 France: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.10.7 France: Malaria Treatment Market, by Distribution Channel
10.2.3.10.7.1 France: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.10.7.2 France: Malaria Treatment Market, by Retail Pharmacies
10.2.3.10.8 France: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.10.8.1 France: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.10.8.2 France: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.11 UK
10.2.3.12 Overview
10.2.3.12.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.12.2 UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.12.3 UK: Malaria Treatment Market, by Treatment
10.2.3.12.4 UK: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.12.5 UK: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.12.6 UK: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.12.7 UK: Malaria Treatment Market, by Distribution Channel
10.2.3.12.7.1 UK: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.12.7.2 UK: Malaria Treatment Market, by Retail Pharmacies
10.2.3.12.8 UK: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.12.8.1 UK: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.12.8.2 UK: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.13 Italy
10.2.3.14 Overview
10.2.3.14.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.14.2 Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.14.3 Italy: Malaria Treatment Market, by Treatment
10.2.3.14.4 Italy: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.14.5 Italy: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.14.6 Italy: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.14.7 Italy: Malaria Treatment Market, by Distribution Channel
10.2.3.14.7.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.14.7.2 Italy: Malaria Treatment Market, by Retail Pharmacies
10.2.3.14.8 Italy: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.14.8.1 Italy: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.14.8.2 Italy: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.15 Germany
10.2.3.16 Overview
10.2.3.16.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.16.2 Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.16.3 Germany: Malaria Treatment Market, by Treatment
10.2.3.16.4 Germany: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.16.5 Germany: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.16.6 Germany: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.16.7 Germany: Malaria Treatment Market, by Distribution Channel
10.2.3.16.7.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.16.7.2 Germany: Malaria Treatment Market, by Retail Pharmacies
10.2.3.16.8 Germany: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.16.8.1 Germany: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.16.8.2 Germany: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.17 Spain
10.2.3.18 Overview
10.2.3.18.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.18.2 Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.18.3 Spain: Malaria Treatment Market, by Treatment
10.2.3.18.4 Spain: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.18.5 Spain: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.18.6 Spain: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.18.7 Spain: Malaria Treatment Market, by Distribution Channel
10.2.3.18.7.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.18.7.2 Spain: Malaria Treatment Market, by Retail Pharmacies
10.2.3.18.8 Spain: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.18.8.1 Spain: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.18.8.2 Spain: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.19 Rest of Europe
10.2.3.20 Overview
10.2.3.20.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.20.2 Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.20.3 Rest of Europe: Malaria Treatment Market, by Treatment
10.2.3.20.4 Rest of Europe: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.20.5 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.20.6 Rest of Europe: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.20.7 Rest of Europe: Malaria Treatment Market, by Distribution Channel
10.2.3.20.7.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.20.7.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
10.2.3.20.8 Rest of Europe: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.20.8.1 Rest of Europe: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.20.8.2 Rest of Europe: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3 Asia Pacific Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.3.1 Overview
10.3.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.1 Asia Pacific: Malaria Treatment Market, by Treatment
10.3.3.2 Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.3 Asia Pacific: Malaria Treatment Market, by Route of Administration
10.3.3.4 Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.5 Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.3.3.5.1 Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.5.2 Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.3.3.6 Asia Pacific: Sickle Cell Treatment Market, by Distribution Channel
10.3.3.6.1 Asia Pacific: Sickle Cell Treatment Market, by Hospital Pharmacies
10.3.3.6.2 Asia Pacific: Sickle Cell Treatment Market, by Retail Pharmacies
10.3.3.7 Asia Pacific: Malaria Treatment Market, by Countries
10.3.3.8 Asia Pacific: Sickle Cell Disease Treatment Market, by Country
10.3.3.9 China
10.3.3.10 Overview
10.3.3.10.1 China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.10.2 China: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.10.3 China: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.10.4 China: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.10.4.1 China: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.10.4.2 China: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.11 Japan
10.3.3.12 Overview
10.3.3.12.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.12.2 Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.12.3 Japan: Malaria Treatment Market, by Treatment
10.3.3.12.4 Japan: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.12.5 Japan: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.12.6 Japan: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.12.7 Japan: Malaria Treatment Market, by Distribution Channel
10.3.3.12.7.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.12.7.2 Japan: Malaria Treatment Market, by Retail Pharmacies
10.3.3.12.8 Japan: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.12.8.1 Japan: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.12.8.2 Japan: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.13 India
10.3.3.14 Overview
10.3.3.14.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.14.2 India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.14.3 India: Malaria Treatment Market, by Treatment
10.3.3.14.4 India: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.14.5 India: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.14.6 India: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.14.7 India: Malaria Treatment Market, by Distribution Channel
10.3.3.14.7.1 India: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.14.7.2 India: Malaria Treatment Market, by Retail Pharmacies
10.3.3.14.8 India: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.14.8.1 India: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.14.8.2 India: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.15 South Korea
10.3.3.16 Overview
10.3.3.16.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.16.2 South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.16.3 South Korea: Malaria Treatment Market, by Treatment
10.3.3.16.4 South Korea: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.16.5 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.16.6 South Korea: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.16.7 South Korea: Malaria Treatment Market, by Distribution Channel
10.3.3.16.7.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.16.7.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
10.3.3.16.8 South Korea: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.16.8.1 South Korea: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.16.8.2 South Korea: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.17 Australia
10.3.3.18 Overview
10.3.3.18.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.18.2 Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.18.3 Australia: Malaria Treatment Market, by Treatment
10.3.3.18.4 Australia: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.18.5 Australia: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.18.6 Australia: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.18.7 Australia: Malaria Treatment Market, by Distribution Channel
10.3.3.18.7.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.18.7.2 Australia: Malaria Treatment Market, by Retail Pharmacies
10.3.3.18.8 Australia: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.18.8.1 Australia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.18.8.2 Australia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.19 Rest of Asia Pacific
10.3.3.20 Overview
10.3.3.20.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.20.2 Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.20.3 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
10.3.3.20.4 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.20.5 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.20.6 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.20.7 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.3.3.20.7.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.20.7.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.3.3.20.8 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.20.8.1 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.20.8.2 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4 Middle East & Africa Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.4.1 Overview
10.4.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.1 Middle East & Africa: Malaria Treatment Market, by Treatment
10.4.3.2 Middle East & Africa: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.3 Middle East & Africa: Malaria Treatment Market, by Route of Administration
10.4.3.4 Middle East & Africa: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.5 Middle East & Africa: Malaria Treatment Market, by Distribution Channel
10.4.3.5.1 Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.5.2 Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
10.4.3.6 Middle East & Africa: Sickle Cell Treatment Market, by Distribution Channel
10.4.3.6.1 Middle East & Africa: Sickle Cell Treatment Market, by Hospital Pharmacies
10.4.3.6.2 Middle East & Africa: Sickle Cell Treatment Market, by Retail Pharmacies
10.4.3.7 Middle East & Africa: Malaria Treatment Market, by Country
10.4.3.8 Middle East & Africa: Sickle Cell Disease Treatment Market, by Country
10.4.3.9 Saudi Arabia
10.4.3.10 Overview
10.4.3.10.1 Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.10.2 Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.10.3 Saudi Arabia: Malaria Treatment Market, by Treatment
10.4.3.10.4 Saudi Arabia: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.10.5 Saudi Arabia: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.10.6 Saudi Arabia: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.10.7 Saudi Arabia: Malaria Treatment Market, by Distribution Channel
10.4.3.10.7.1 Saudi Arabia: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.10.7.2 Saudi Arabia: Malaria Treatment Market, by Retail Pharmacies
10.4.3.10.8 Saudi Arabia: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.10.8.1 Saudi Arabia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.10.8.2 Saudi Arabia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.11 UAE
10.4.3.12 Overview
10.4.3.12.1 UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.12.2 UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.12.3 UAE: Malaria Treatment Market, by Treatment
10.4.3.12.4 UAE: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.12.5 UAE: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.12.6 UAE: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.12.7 UAE: Malaria Treatment Market, by Distribution Channel
10.4.3.12.7.1 UAE: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.12.7.2 UAE: Malaria Treatment Market, by Retail Pharmacies
10.4.3.12.8 UAE: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.12.8.1 UAE: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.12.8.2 UAE: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.13 South Africa
10.4.3.14 Overview
10.4.3.14.1 South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.14.2 South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.14.3 South Africa: Malaria Treatment Market, by Treatment
10.4.3.14.4 South Africa: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.14.5 South Africa: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.14.6 South Africa: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.14.7 South Africa: Malaria Treatment Market, by Distribution Channel
10.4.3.14.7.1 South Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.14.7.2 South Africa: Malaria Treatment Market, by Retail Pharmacies
10.4.3.14.8 South Africa: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.14.8.1 South Africa: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.14.8.2 South Africa: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.15 Kenya
10.4.3.16 Overview
10.4.3.16.1 Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.16.2 Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.16.3 Kenya: Malaria Treatment Market, by Treatment
10.4.3.16.4 Kenya: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.16.5 Kenya: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.16.6 Kenya: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.16.7 Kenya: Malaria Treatment Market, by Distribution Channel
10.4.3.16.7.1 Kenya: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.16.7.2 Kenya: Malaria Treatment Market, by Retail Pharmacies
10.4.3.16.8 Kenya: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.16.8.1 Kenya: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.16.8.2 Kenya: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.17 Tanzania
10.4.3.18 Overview
10.4.3.18.1 Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.18.2 Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.18.3 Tanzania: Malaria Treatment Market, by Treatment
10.4.3.18.4 Tanzania: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.18.5 Tanzania: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.18.6 Tanzania: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.18.7 Tanzania: Malaria Treatment Market, by Distribution Channel
10.4.3.18.7.1 Tanzania: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.18.7.2 Tanzania: Malaria Treatment Market, by Retail Pharmacies
10.4.3.18.8 Tanzania: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.18.8.1 Tanzania: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.18.8.2 Tanzania: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.19 Rwanda
10.4.3.20 Overview
10.4.3.20.1 Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.20.2 Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.20.3 Rwanda: Malaria Treatment Market, by Treatment
10.4.3.20.4 Rwanda: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.20.5 Rwanda: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.20.6 Rwanda: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.20.7 Rwanda: Malaria Treatment Market, by Distribution Channel
10.4.3.20.7.1 Rwanda: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.20.7.2 Rwanda: Malaria Treatment Market, by Retail Pharmacies
10.4.3.20.8 Rwanda: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.20.8.1 Rwanda: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.20.8.2 Rwanda: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.21 Nigeria
10.4.3.22 Overview
10.4.3.22.1 Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.22.2 Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.22.3 Nigeria: Malaria Treatment Market, by Treatment
10.4.3.22.4 Nigeria: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.22.5 Nigeria: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.22.6 Nigeria: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.22.7 Nigeria: Malaria Treatment Market, by Distribution Channel
10.4.3.22.7.1 Nigeria: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.22.7.2 Nigeria: Malaria Treatment Market, by Retail Pharmacies
10.4.3.22.8 Nigeria: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.22.8.1 Nigeria: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.22.8.2 Nigeria: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.23 Ghana
10.4.3.24 Overview
10.4.3.24.1 Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.24.2 Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.24.3 Ghana: Malaria Treatment Market, by Treatment
10.4.3.24.4 Ghana: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.24.5 Ghana: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.24.6 Ghana: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.24.7 Ghana: Malaria Treatment Market, by Distribution Channel
10.4.3.24.7.1 Ghana: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.24.7.2 Ghana: Malaria Treatment Market, by Retail Pharmacies
10.4.3.24.8 Ghana: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.24.8.1 Ghana: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.24.8.2 Ghana: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.25 Uganda
10.4.3.26 Overview
10.4.3.26.1 Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.26.2 Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.26.3 Uganda: Malaria Treatment Market, by Treatment
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Sickle Cell Disease Drugs/Vaccine/Compounds Under Clinical Development
Table 4. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 5. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 6. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 7. Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 8. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
Table 9. Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
Table 10. North America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 11. North America: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 12. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
Table 13. North America: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
Table 14. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
Table 15. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 16. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 17. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
Table 18. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 19. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
Table 20. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 21. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 22. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 23. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 24. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 25. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 26. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 27. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 28. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 29. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 30. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 31. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 32. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 33. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 34. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 35. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 36. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 37. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 38. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 39. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 40. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 41. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 42. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 43. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 44. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 45. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 46. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 47. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 48. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 49. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 50. Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 51. Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 52. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
Table 53. Europe: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
Table 54. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
Table 55. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 56. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 57. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
Table 58. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 59. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
Table 60. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 61. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 62. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 63. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 64. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 65. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 66. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 67. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 68. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 69. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 70. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 71. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 72. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 73. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 74. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 75. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 76. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 77. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 78. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 79. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 80. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 81. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 82. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 83. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 84. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 85. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 86. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 87. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 88. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 89. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 90. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 91. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 92. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 93. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 94. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 95. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 96. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 97. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 98. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 99. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 100. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 101. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 102. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 103. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 104. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 105. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 106. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 107. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 108. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 109. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 110. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 111. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 112. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 113. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 114. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 115. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 116. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 117. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 118. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 119. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 120. Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 121. Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 122. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
Table 123. Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
Table 124. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
Table 125. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 126. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 127. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
Table 128. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 129. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
Table 130. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 131. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 132. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 133. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 134. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 135. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 136. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 137. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 138. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 139. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 140. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 141. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 142. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 143. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 144. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 145. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 146. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 147. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 148. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 149. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 150. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 151. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 152. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 153. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 154. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 155. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 156. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 157. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 158. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 159. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 160. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 161. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 162. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 163. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 164. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 165. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 166. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 167. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 168. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 169. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 170. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 171. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 172. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 173. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 174. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 175. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 176. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 177. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 178. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 179. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 180. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 181. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 182. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 183. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 184. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 185. Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 186. Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 187. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
Table 188. Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
Table 189. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
Table 190. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 191. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 192. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
Table 193. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 194. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
Table 195. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 196. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 197. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 198. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 199. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 200. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 201. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 202. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 203. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 204. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 205. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 206. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 207. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 208. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 209. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 210. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 211. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 212. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 213. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 214. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 215. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 216. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 217. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 218. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 219. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 220. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 221. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 222. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 223. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 224. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 225. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 226. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 227. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 228. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 229. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 230. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 231. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 232. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 233. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 234. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 235. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 236. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 237. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 238. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 239. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 240. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 241. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 242. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 243. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 244. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 245. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 246. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 247. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 248. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 249. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 250. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 251. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 252. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 253. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 254. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 255. Nigeria Malaria Treatment Market, by Treatment - Revenue and Forecast to 2030 (USD Million)
Table 256. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 257. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 258. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 259. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 260. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 261. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 262. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 263. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 264. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 265. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 266. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 267. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 268. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 269. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 270. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 271. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 272. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 273. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 274. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 275. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 276. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 277. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 278. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 279. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 280. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Figure 2. PEST Analysis - Sickle Cell Disease Treatment
Figure 3. Malaria and Sickle Cell Disease Treatment Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Malaria Treatment Market Revenue (US$ million), 2020 - 2030
Figure 6. Sickle Cell Disease Treatment Market Revenue (US$ million), 2020 - 2030
Figure 7. Malaria: Geography Analysis Market Revenue (US$ million), 2022 - 2030
Figure 8. Sickle Cell Disease: Geography Analysis Market Revenue (US$ million), 2022 - 2030
Figure 9. Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 10. Sickle Cell Disease Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 11. Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 14. Sickle Cell Disease Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 15. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Oral: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Parenteral: Malaria and Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Parenteral: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 20. Sickle Cell Disease Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 21. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Direct Tender: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hospital Pharmacies: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Retail Pharmacies: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Online Pharmacies: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Others: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. North America Malaria Treatment Market, By Geography, 2022 ($Mn)
Figure 32. North America Sickle Cell Disease Treatment Market, By Geography, 2022 ($Mn)
Figure 33. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. North America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 36. North America: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 37. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. US: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Canada: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Mexico: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Europe Malaria Treatment Market, By Geography, 2022 ($Mn)
Figure 44. Europe Malaria and Sickle Cell Disease Treatment Market, By Geography, 2022 ($Mn)
Figure 45. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Europe: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 48. Europe: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 49. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. France: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 51. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. UK: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Italy: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 56. Germany: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 58. Spain: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Rest of Europe: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Malaria Treatment Market, 2022 ($Mn)
Figure 62. Sickle Cell Disease Treatment Market, 2022 ($Mn)
Figure 63. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 64. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 65. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 66. Asia Pacific: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 67. China: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 68. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 69. Japan: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 70. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 71. India: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 72. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 73. South Korea: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 74. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 75. Australia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 76. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 77. Rest of Asia Pacific: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 78. Malaria Treatment Market, 2022 (US$ Mn)
Figure 79. Sickle Cell Disease Treatment Market, 2022 (US$ Mn)
Figure 80. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 81. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 82. Middle East & Africa: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 83. Middle East & Africa: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 84. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 85. Saudi Arabia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 86. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 87. UAE: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 88. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 89. South Africa: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 90. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 91. Kenya: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 92. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 93. Tanzania: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 94. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 95. Rwanda: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 96. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 97. Nigeria: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 98. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 99. Ghana: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 100. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 101. Uganda: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 102. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 103. Angola: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 104. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 105. Cameroon: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 106. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 107. Senegal: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 108. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 109. Zambia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 110. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 111. Rest of Middle East & Africa: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 112. Malaria Treatment Market, 2022 ($Mn)
Figure 113. Sickle Cell Disease Treatment Market, 2022 ($Mn)
Figure 114. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 115. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 116. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 117. Asia Pacific: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 118. China: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 119. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 120. Japan: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 121. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 122. India: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 123. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 124. South Korea: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 125. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 126. Australia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 127. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 128. Rest of Asia Pacific: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 129. Malaria Treatment Market, 2022 ($Mn)
Figure 130. Sickle Cell Disease Treatment Market, 2022 ($Mn)
Figure 131. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 132. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 133. South & Central America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 134. South & Central America: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 135. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 136. Brazil: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 137. Argentina: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 138. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 139. Rest of South & Central America: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 140. Growth Strategies in the Malaria and Sickle Cell Disease Treatment Market
Companies Mentioned
- Cipla Ltd
- Pfizer Inc
- Sun Pharmaceutical Industries Ltd
- Sanofi SA
- GSK Plc
- Novartis AG
- Pfizer Inc
- Emmaus Life Sciences Inc
- AdvaCare Pharma USA LLC
- VLP Therapeutics LLC
- Lupin Ltd
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 420 |
Published | November 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value in 2022 | 4.46 Billion |
Forecasted Market Value by 2030 | 29.18 Billion |
Compound Annual Growth Rate | 26.5% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |